Creatine Monohydrate.

Creatine keeps the phosphocreatine pool topped up so muscles can rapidly regenerate ATP in the first seconds of a maximal effort, while beta-alanine raises muscle carnosine, the buffer that soaks up the acidity that builds as high-intensity work continues. They support different, consecutive stages of the same energy demand, which is the long-standing reason the two are stacked together.

Building creatine in the body is the largest single use of methyl groups, drawing on the same S-adenosylmethionine pool that betaine helps refill by remethylating homocysteine back into methionine. Supplemental creatine lowers that methylation demand while betaine feeds the cycle that supplies it, and both also act as osmolytes that pull water into muscle cells.

Creatine acts through creatine kinase, the enzyme that shuttles a phosphate between phosphocreatine and ADP to regenerate ATP, and that reaction depends on magnesium because the cell uses ATP as its magnesium complex. Magnesium is the cofactor the phosphocreatine energy system runs on, so it works in the same machinery creatine feeds.

AGAT joins arginine and glycine into guanidinoacetate, the first committed step of creatine synthesis. Glycine supply sits directly upstream of the molecule.

Arginine donates the guanidino group that AGAT transfers onto glycine to begin creatine synthesis. The two feed one pathway.

The final step is a methyl transfer by GAMT using SAM as the donor, which makes creatine synthesis one of the largest single consumers of SAM.

Choline oxidises to betaine, which re-methylates homocysteine back to methionine and refills the SAM pool GAMT draws on. Choline-derived methyl groups ease the load creatine synthesis places on methylation.

B12-dependent methionine synthase regenerates methionine, which becomes the SAM used to methylate guanidinoacetate into creatine. Lower B12 status leaves less methyl capacity for that step.

Folate carries the one-carbon unit used to regenerate methionine, keeping the SAM pool that creatine synthesis spends topped up. Folate and creatine share the methylation circuit.

Creatine enters muscle via CRT1 (SLC6A8), which is sodium and chloride dependent, so sodium is part of the transport step. Both also raise intracellular water, the reason they share loading formulas.

Taurine and creatine are both muscle osmolytes moved by sodium-dependent SLC6 family transporters and both increase intracellular water. Their uptake is linked through that shared transporter family.

Creatine transport into muscle responds to insulin signalling, and alpha lipoic acid increases insulin sensitivity and muscle glucose uptake. It acts as a carrier for loading rather than on its own.

Caffeine has been reported to blunt the performance gain from creatine loading even when muscle creatine rose, and the two work against each other on muscle relaxation time and fluid retention. Separating them in time is the usual formulation answer.

HMB and creatine are often stacked on the assumption that a leucine metabolite and a phosphagen substrate act on different parts of the same training response. A randomised trial adding HMB to creatine monohydrate did not detect improvements in anthropometric or performance measures beyond creatine alone. That is a failure to detect a difference in that trial, not evidence that no difference exists. The pairing remains reasonable to formulate, without an expectation of an additive result.

Creatine enters muscle through the sodium- and chloride-dependent transporter CRT1, and transporter activity rises with an insulin stimulus, which is why creatine is commonly co-ingested with protein and carbohydrate. A trial of creatine taken with carbohydrate and protein reported effects on repeated sprint performance for the combination. Protein also supplies the amino acid substrate for the training adaptation creatine supports. The two act on different limiting steps rather than the same one.

Endogenous creatine synthesis consumes S-adenosylmethionine, and methionine is the amino acid from which S-adenosylmethionine is made. Creatine synthesis is one of the largest single consumers of labile methyl groups in the body. Taking creatine reduces the demand the synthesis pathway places on methionine-derived methyl groups. The relationship is a substrate accounting one, not a performance claim.

Creatine acts inside the cell by regenerating ATP from ADP through the creatine kinase reaction, which also consumes a proton. Bicarbonate acts outside the cell, raising extracellular buffering capacity and proton efflux. The two address the same limiting factor in repeated high-intensity work at different sites. Stacking them is mechanistically coherent, and the size of any combined effect is not settled.

Leucine is the amino acid that signals most strongly through mTORC1 to start muscle protein synthesis, while creatine increases the energy available for the training that drives that signal. They occupy separate steps: one is a signal, one is a substrate for work. Co-supplementation is common in post-training formulas for that reason.

Coenzyme Q10 carries electrons in the mitochondrial respiratory chain, which is where ATP is made, while creatine buffers and shuttles the phosphate group that keeps cytosolic ATP available between contractions. The two sit on either side of the same energy transfer. Human data on the combination is thin, so this is a mechanistic pairing rather than a measured one.

Casein is often paired with creatine in evening or slow-release products because its gastric clotting slows amino acid delivery while creatine loading is dose-dependent rather than timing-dependent. The combination is a convenience of formulation with a plausible substrate rationale. No trial isolates the casein contribution.

Vitamin D receptor signalling in skeletal muscle influences fibre size and calcium handling, both of which shape how much a phosphagen substrate can be used. Studies pairing them in older adults report muscle and bone measures rather than isolating the interaction. This is an association-level rationale, not a demonstrated causal synergy.

Both creatine and inositol act as intracellular osmolytes, and cells adjust one osmolyte pool when another rises. Creatine loading increases intracellular water, which is part of why lean mass measures move early. Whether an added osmolyte changes that is not established in humans.

Glutamine and creatine are both cell-volumising amino compounds routinely blended in recovery powders. Each is taken up by its own transporter, so they do not compete for entry. The pairing is common in practice and has little combination evidence behind it.